Antiviral Drug Resistance Market, Global Outlook and Forecast 2023-2028

Report ID: 1314504 | Published Date: Jan 2025 | No. of Page: 65 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Antiviral Drug Resistance Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Antiviral Drug Resistance Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Antiviral Drug Resistance Overall Market Size
    2.1 Global Antiviral Drug Resistance Market Size: 2021 VS 2028
    2.2 Global Antiviral Drug Resistance Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Antiviral Drug Resistance Players in Global Market
    3.2 Top Global Antiviral Drug Resistance Companies Ranked by Revenue
    3.3 Global Antiviral Drug Resistance Revenue by Companies
    3.4 Top 3 and Top 5 Antiviral Drug Resistance Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Antiviral Drug Resistance Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Antiviral Drug Resistance Players in Global Market
        3.6.1 List of Global Tier 1 Antiviral Drug Resistance Companies
        3.6.2 List of Global Tier 2 and Tier 3 Antiviral Drug Resistance Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Antiviral Drug Resistance Market Size Markets, 2021 & 2028
        4.1.2 Immunodiagnostics
        4.1.3 Polymerase Chain Reaction (PCR)
        4.1.4 Next Generation Sequencing (NGS)
        4.1.5 Sanger Sequencing
        4.1.6 Other Technologies
    4.2 By Type - Global Antiviral Drug Resistance Revenue & Forecasts
        4.2.1 By Type - Global Antiviral Drug Resistance Revenue, 2017-2022
        4.2.2 By Type - Global Antiviral Drug Resistance Revenue, 2023-2028
        4.2.3 By Type - Global Antiviral Drug Resistance Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Antiviral Drug Resistance Market Size, 2021 & 2028
        5.1.2 Hospitals & Clinics
        5.1.3 Pathology or Diagnostic Laboratories
        5.1.4 Research Institutes
        5.1.5 Others
    5.2 By Application - Global Antiviral Drug Resistance Revenue & Forecasts
        5.2.1 By Application - Global Antiviral Drug Resistance Revenue, 2017-2022
        5.2.2 By Application - Global Antiviral Drug Resistance Revenue, 2023-2028
        5.2.3 By Application - Global Antiviral Drug Resistance Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Antiviral Drug Resistance Market Size, 2021 & 2028
    6.2 By Region - Global Antiviral Drug Resistance Revenue & Forecasts
        6.2.1 By Region - Global Antiviral Drug Resistance Revenue, 2017-2022
        6.2.2 By Region - Global Antiviral Drug Resistance Revenue, 2023-2028
        6.2.3 By Region - Global Antiviral Drug Resistance Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Antiviral Drug Resistance Revenue, 2017-2028
        6.3.2 US Antiviral Drug Resistance Market Size, 2017-2028
        6.3.3 Canada Antiviral Drug Resistance Market Size, 2017-2028
        6.3.4 Mexico Antiviral Drug Resistance Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Antiviral Drug Resistance Revenue, 2017-2028
        6.4.2 Germany Antiviral Drug Resistance Market Size, 2017-2028
        6.4.3 France Antiviral Drug Resistance Market Size, 2017-2028
        6.4.4 U.K. Antiviral Drug Resistance Market Size, 2017-2028
        6.4.5 Italy Antiviral Drug Resistance Market Size, 2017-2028
        6.4.6 Russia Antiviral Drug Resistance Market Size, 2017-2028
        6.4.7 Nordic Countries Antiviral Drug Resistance Market Size, 2017-2028
        6.4.8 Benelux Antiviral Drug Resistance Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Antiviral Drug Resistance Revenue, 2017-2028
        6.5.2 China Antiviral Drug Resistance Market Size, 2017-2028
        6.5.3 Japan Antiviral Drug Resistance Market Size, 2017-2028
        6.5.4 South Korea Antiviral Drug Resistance Market Size, 2017-2028
        6.5.5 Southeast Asia Antiviral Drug Resistance Market Size, 2017-2028
        6.5.6 India Antiviral Drug Resistance Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Antiviral Drug Resistance Revenue, 2017-2028
        6.6.2 Brazil Antiviral Drug Resistance Market Size, 2017-2028
        6.6.3 Argentina Antiviral Drug Resistance Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Antiviral Drug Resistance Revenue, 2017-2028
        6.7.2 Turkey Antiviral Drug Resistance Market Size, 2017-2028
        6.7.3 Israel Antiviral Drug Resistance Market Size, 2017-2028
        6.7.4 Saudi Arabia Antiviral Drug Resistance Market Size, 2017-2028
        6.7.5 UAE Antiviral Drug Resistance Market Size, 2017-2028
7 Players Profiles
    7.1 AccuBioTech Co., Ltd.
        7.1.1 AccuBioTech Co., Ltd. Corporate Summary
        7.1.2 AccuBioTech Co., Ltd. Business Overview
        7.1.3 AccuBioTech Co., Ltd. Antiviral Drug Resistance Major Product Offerings
        7.1.4 AccuBioTech Co., Ltd. Antiviral Drug Resistance Revenue in Global Market (2017-2022)
        7.1.5 AccuBioTech Co., Ltd. Key News
    7.2 ACON Laboratories, Inc.
        7.2.1 ACON Laboratories, Inc. Corporate Summary
        7.2.2 ACON Laboratories, Inc. Business Overview
        7.2.3 ACON Laboratories, Inc. Antiviral Drug Resistance Major Product Offerings
        7.2.4 ACON Laboratories, Inc. Antiviral Drug Resistance Revenue in Global Market (2017-2022)
        7.2.5 ACON Laboratories, Inc. Key News
    7.3 Siemens AG
        7.3.1 Siemens AG Corporate Summary
        7.3.2 Siemens AG Business Overview
        7.3.3 Siemens AG Antiviral Drug Resistance Major Product Offerings
        7.3.4 Siemens AG Antiviral Drug Resistance Revenue in Global Market (2017-2022)
        7.3.5 Siemens AG Key News
    7.4 BioMerieux SA
        7.4.1 BioMerieux SA Corporate Summary
        7.4.2 BioMerieux SA Business Overview
        7.4.3 BioMerieux SA Antiviral Drug Resistance Major Product Offerings
        7.4.4 BioMerieux SA Antiviral Drug Resistance Revenue in Global Market (2017-2022)
        7.4.5 BioMerieux SA Key News
    7.5 Bio-Rad Laboratories, Inc.
        7.5.1 Bio-Rad Laboratories, Inc. Corporate Summary
        7.5.2 Bio-Rad Laboratories, Inc. Business Overview
        7.5.3 Bio-Rad Laboratories, Inc. Antiviral Drug Resistance Major Product Offerings
        7.5.4 Bio-Rad Laboratories, Inc. Antiviral Drug Resistance Revenue in Global Market (2017-2022)
        7.5.5 Bio-Rad Laboratories, Inc. Key News
    7.6 Danaher
        7.6.1 Danaher Corporate Summary
        7.6.2 Danaher Business Overview
        7.6.3 Danaher Antiviral Drug Resistance Major Product Offerings
        7.6.4 Danaher Antiviral Drug Resistance Revenue in Global Market (2017-2022)
        7.6.5 Danaher Key News
    7.7 Abbott
        7.7.1 Abbott Corporate Summary
        7.7.2 Abbott Business Overview
        7.7.3 Abbott Antiviral Drug Resistance Major Product Offerings
        7.7.4 Abbott Antiviral Drug Resistance Revenue in Global Market (2017-2022)
        7.7.5 Abbott Key News
    7.8 BD
        7.8.1 BD Corporate Summary
        7.8.2 BD Business Overview
        7.8.3 BD Antiviral Drug Resistance Major Product Offerings
        7.8.4 BD Antiviral Drug Resistance Revenue in Global Market (2017-2022)
        7.8.5 BD Key News
    7.9 F. Hoffmann-La Roche Ltd.
        7.9.1 F. Hoffmann-La Roche Ltd. Corporate Summary
        7.9.2 F. Hoffmann-La Roche Ltd. Business Overview
        7.9.3 F. Hoffmann-La Roche Ltd. Antiviral Drug Resistance Major Product Offerings
        7.9.4 F. Hoffmann-La Roche Ltd. Antiviral Drug Resistance Revenue in Global Market (2017-2022)
        7.9.5 F. Hoffmann-La Roche Ltd. Key News
    7.10 Trinity Biotech
        7.10.1 Trinity Biotech Corporate Summary
        7.10.2 Trinity Biotech Business Overview
        7.10.3 Trinity Biotech Antiviral Drug Resistance Major Product Offerings
        7.10.4 Trinity Biotech Antiviral Drug Resistance Revenue in Global Market (2017-2022)
        7.10.5 Trinity Biotech Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Antiviral Drug Resistance Market Opportunities & Trends in Global Market
    Table 2. Antiviral Drug Resistance Market Drivers in Global Market
    Table 3. Antiviral Drug Resistance Market Restraints in Global Market
    Table 4. Key Players of Antiviral Drug Resistance in Global Market
    Table 5. Top Antiviral Drug Resistance Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Antiviral Drug Resistance Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Antiviral Drug Resistance Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Antiviral Drug Resistance Product Type
    Table 9. List of Global Tier 1 Antiviral Drug Resistance Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Antiviral Drug Resistance Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Antiviral Drug Resistance Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Antiviral Drug Resistance Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Antiviral Drug Resistance Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Antiviral Drug Resistance Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Antiviral Drug Resistance Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Antiviral Drug Resistance Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Antiviral Drug Resistance Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Antiviral Drug Resistance Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Antiviral Drug Resistance Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Antiviral Drug Resistance Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Antiviral Drug Resistance Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Antiviral Drug Resistance Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Antiviral Drug Resistance Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Antiviral Drug Resistance Revenue, (US$, Mn), 2023-2028
    Table 30. AccuBioTech Co., Ltd. Corporate Summary
    Table 31. AccuBioTech Co., Ltd. Antiviral Drug Resistance Product Offerings
    Table 32. AccuBioTech Co., Ltd. Antiviral Drug Resistance Revenue (US$, Mn), (2017-2022)
    Table 33. ACON Laboratories, Inc. Corporate Summary
    Table 34. ACON Laboratories, Inc. Antiviral Drug Resistance Product Offerings
    Table 35. ACON Laboratories, Inc. Antiviral Drug Resistance Revenue (US$, Mn), (2017-2022)
    Table 36. Siemens AG Corporate Summary
    Table 37. Siemens AG Antiviral Drug Resistance Product Offerings
    Table 38. Siemens AG Antiviral Drug Resistance Revenue (US$, Mn), (2017-2022)
    Table 39. BioMerieux SA Corporate Summary
    Table 40. BioMerieux SA Antiviral Drug Resistance Product Offerings
    Table 41. BioMerieux SA Antiviral Drug Resistance Revenue (US$, Mn), (2017-2022)
    Table 42. Bio-Rad Laboratories, Inc. Corporate Summary
    Table 43. Bio-Rad Laboratories, Inc. Antiviral Drug Resistance Product Offerings
    Table 44. Bio-Rad Laboratories, Inc. Antiviral Drug Resistance Revenue (US$, Mn), (2017-2022)
    Table 45. Danaher Corporate Summary
    Table 46. Danaher Antiviral Drug Resistance Product Offerings
    Table 47. Danaher Antiviral Drug Resistance Revenue (US$, Mn), (2017-2022)
    Table 48. Abbott Corporate Summary
    Table 49. Abbott Antiviral Drug Resistance Product Offerings
    Table 50. Abbott Antiviral Drug Resistance Revenue (US$, Mn), (2017-2022)
    Table 51. BD Corporate Summary
    Table 52. BD Antiviral Drug Resistance Product Offerings
    Table 53. BD Antiviral Drug Resistance Revenue (US$, Mn), (2017-2022)
    Table 54. F. Hoffmann-La Roche Ltd. Corporate Summary
    Table 55. F. Hoffmann-La Roche Ltd. Antiviral Drug Resistance Product Offerings
    Table 56. F. Hoffmann-La Roche Ltd. Antiviral Drug Resistance Revenue (US$, Mn), (2017-2022)
    Table 57. Trinity Biotech Corporate Summary
    Table 58. Trinity Biotech Antiviral Drug Resistance Product Offerings
    Table 59. Trinity Biotech Antiviral Drug Resistance Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Antiviral Drug Resistance Segment by Type in 2021
    Figure 2. Antiviral Drug Resistance Segment by Application in 2021
    Figure 3. Global Antiviral Drug Resistance Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Antiviral Drug Resistance Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Antiviral Drug Resistance Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Antiviral Drug Resistance Revenue in 2021
    Figure 8. By Type - Global Antiviral Drug Resistance Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Antiviral Drug Resistance Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Antiviral Drug Resistance Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Antiviral Drug Resistance Revenue Market Share, 2017-2028
    Figure 12. US Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Antiviral Drug Resistance Revenue Market Share, 2017-2028
    Figure 16. Germany Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2028
    Figure 17. France Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Antiviral Drug Resistance Revenue Market Share, 2017-2028
    Figure 24. China Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2028
    Figure 28. India Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Antiviral Drug Resistance Revenue Market Share, 2017-2028
    Figure 30. Brazil Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Antiviral Drug Resistance Revenue Market Share, 2017-2028
    Figure 33. Turkey Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Antiviral Drug Resistance Revenue, (US$, Mn), 2017-2028
    Figure 37. AccuBioTech Co., Ltd. Antiviral Drug Resistance Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. ACON Laboratories, Inc. Antiviral Drug Resistance Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Siemens AG Antiviral Drug Resistance Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. BioMerieux SA Antiviral Drug Resistance Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Bio-Rad Laboratories, Inc. Antiviral Drug Resistance Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Danaher Antiviral Drug Resistance Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Abbott Antiviral Drug Resistance Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. BD Antiviral Drug Resistance Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. F. Hoffmann-La Roche Ltd. Antiviral Drug Resistance Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Trinity Biotech Antiviral Drug Resistance Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
65
Frequently Asked Questions
Antiviral Drug Resistance Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Antiviral Drug Resistance Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Antiviral Drug Resistance Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Pediatric MRI Market

Pediatric magnetic resonance imaging (MRI) uses a magnetic field, radio waves, and a computer to  ... Read More